21
-
30
of
80
results (0.36 seconds)
Sort By:
-
A Strategic Analysis of the U.S. Life Insurance Industry Part II: Products
A Strategic Analysis of the U.S. Life Insurance Industry Part II: Products This is the second article in a four–part series. In this article, the industry's products are examined. N/A; A ...- Authors: Narayan S Shankar
- Date: Jun 2005
- Competency: External Forces & Industry Knowledge
- Publication Name: The Actuary Magazine
- Topics: Annuities; Health & Disability>Health insurance; Life Insurance
-
Biosimilars, Part 6: Maximizing Adoption
Biosimilars, Part 6: Maximizing Adoption The coming wave of biosimilars could have a major impact on prescription drug spend in coming years. The big event of Humira biosimilar launches in 2023 ...- Authors: Tony Pistilli, Greg Warren
- Date: Jan 2024
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability
-
From First-Timer to Advocate: Unpacking the SOA Health Meeting Experience
From First-Timer to Advocate: Unpacking the SOA Health Meeting Experience Chris Smith, vice chair of the Actuary of the Future section, had the privilege of attending the SOA Health meeting in ...- Date: Jan 2024
- Competency: Relationship Management
- Publication Name: Actuary of the Future
- Topics: Actuarial Profession>Professional associations; Actuarial Profession>Professional development; Health & Disability
-
A Healthy Future? Risks and Opportunities Facing the Health Discipline
A Healthy Future? Risks and Opportunities Facing the Health Discipline This article examines the dynamic environment of the health care system in the United States and the challenges facing the ...- Authors: Jim Toole
- Date: Apr 2008
- Competency: External Forces & Industry Knowledge
- Publication Name: The Actuary Magazine
- Topics: Actuarial Profession>Professional development; Health & Disability>Health care
-
Biosimilars, Part 3: Humira Biosimilar Launches
Biosimilars, Part 3: Humira Biosimilar Launches The big event of 2023 is the launch of multiple Humira biosimilars, which began in January with the arrival of Amgen’s Amjevita on the market. The ...- Authors: Tony Pistilli, Greg Warren
- Date: Nov 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance; Public Policy; Public Policy; Public Policy
-
Health Reinsurers Brace for Cell and Gene Therapy
Health Reinsurers Brace for Cell and Gene Therapy Cell and Gene Therapy (CGT) are life-changing treatments where conditions such as cancer, hemophilia, spinal muscular atrophy and blindness are ...- Authors: Mehboob Khoja
- Date: Apr 2021
- Competency: External Forces & Industry Knowledge
- Publication Name: Reinsurance News
- Topics: Health & Disability; Reinsurance>Health reinsurance; Reinsurance>Pricing - Reinsurance; Reinsurance>Reserving - Reinsurance; Reinsurance>Stop-loss insurance
-
Spotlight on Supplemental Health Products in the Worksite Market
Spotlight on Supplemental Health Products in the Worksite Market Two industry experts are interviewed about supplemental health insurance. Read what they have to say. By Jill Klibanov Marketing ...- Authors: Jillian Klibanov
- Date: May 2014
- Competency: Technical Skills & Analytical Problem Solving>Innovative solutions; Technical Skills & Analytical Problem Solving>Process and technique refinement
- Publication Name: News Direct
- Topics: Health & Disability>Health insurance
-
Intimate Partner Violence: The Shadow Pandemic Part 1: Background Briefing
Intimate Partner Violence: The Shadow Pandemic Part 1: Background Briefing In this paper, we shine a light on the global public health epidemic of intimate partner violence (IPV). This first ...- Date: Mar 2021
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability>Health care; Health & Disability>Health care quality; Health & Disability>Health risks
-
Enhancing the Value of Critical Illness Insurance
Enhancing the Value of Critical Illness Insurance Critical illness insurance is a popular supplemental health insurance product in the U.S. market. This article discusses how carriers have ...- Authors: Ashlee Borcan
- Date: Feb 2022
- Competency: External Forces & Industry Knowledge; Results-Oriented Solutions; Strategic Insight and Integration
- Publication Name: Product Matters!
- Topics: Health & Disability; Health & Disability>Critical illness insurance
-
Future of Group Benefits in Canada
Future of Group Benefits in Canada By Melissa Carruthers A description of the keys to future success in the Canadian group benefits business. Consumer-driven health plans;Group health plans; ...- Authors: Melissa Carruthers
- Date: May 2018
- Competency: Strategic Insight and Integration>Big picture view; Strategic Insight and Integration>Effective decision-making; Strategic Insight and Integration>Influence decisions; Strategic Insight and Integration>Management partnership; Strategic Insight and Integration>Strategy development
- Publication Name: Innovators & Entrepreneurs
- Topics: Health & Disability>Health insurance